After a decade of experience, HPV vaccination completion rates remain <50% in most states.
Cancers caused by human papillomavirus (HPV) are all prevented by HPV vaccination prior to infection. The American Academy of Pediatrics recommends routine HPV vaccination at ages 9 to 12 years for both boys and girls. Despite this, vaccine administration in the U.S. lags that in other countries by significant margins.
Researchers analyzed a dataset from 2008 through 2018 for HPV vaccine series initiation and completion within ages 9 to 12 years (beginning in 2010, both boys and girls were included in the vaccination recommendation). Initiation of HPV vaccination rose from 17% (2008) to 63% (2018); however, completion rates increased less markedly (from 14% [2011] to 33% [2018]). Among Hispanic populations in 2018, the completion rate was 41…
Reviewing Author
DisclosuresGrant/Research SupportNIH Institutional Clinical and Translational Science Award; Agency for Healthcare Research and Quality National Center for Pediatric Practice Based Research Learning; Patient-Centered Outcomes Research Institute
Editorial BoardsCurrent Problems in Pediatric Adolescent Healthcare
Leadership Positions in Professional Societies College of Physicians of Philadelphia (Board of Trustees)
DisclosuresGrant/Research SupportNIH Institutional Clinical and Translational Science Award; Agency for Healthcare Research and Quality National Center for Pediatric Practice Based Research Learning; Patient-Centered Outcomes Research Institute
Editorial BoardsCurrent Problems in Pediatric Adolescent Healthcare
Leadership Positions in Professional Societies College of Physicians of Philadelphia (Board of Trustees)